American Association for Cancer Research

AACR Cancer Policy Monitor

Bookmark and Share
CPM
November 2011

 

SENATE RESOLUTION TO COMMEMORATE NATIONAL CANCER ACT  

Encourage your senators to lend their support

U.S. Senators Sherrod Brown (D-Ohio), Jerry Moran (R-Kan.) and John Kerry (D-Mass.) are preparing to introduce a congressional resolution that reaffirms the national commitment to understanding and controlling cancer.

The resolution will commemorate the 40th anniversary of the signing of the National Cancer Act of 1971, which set the nation on a concerted course to conquer cancer through investment in cancer research and related biomedical science. It will also pay tribute to the more than 12 million cancer survivors who are alive today because of the country’s commitment to accelerate progress in preventing, detecting, diagnosing and treating cancer.

The senators are currently asking their colleagues to cosponsor the resolution and hope to have as much support as possible behind the measure before officially introducing it, and hopefully, passing it in December.

The AACR, which worked closely with the Senate offices on the development of the resolution, has strongly endorsed it and hopes that it will generate significant support in the Senate. This support is especially symbolic as lawmakers grapple with spending proposals for fiscal year 2012 and beyond. The resolution will remind them of the importance of robust investment in the National Cancer Institute (NCI) and its parent agency, the National Institutes of Health (NIH).

Act Now! Encourage your senators to show their support for cancer research.

The resolution also complements a landmark cancer progress report recently released by the AACR that illustrates the astounding return on investment in cancer research and biomedical science supported through the NIH and the NCI, and provides a summary of the scientific breakthroughs that promise to revolutionize the prevention, detection, diagnosis and treatment of cancer.

Links:

Read more from the November edition of the AACR Cancer Policy Monitor:

 

Top